Inflammatory linear verrucous epidermal nevus and epilepsy: remission during valproic acid therapy
Diluvio, L.; Campione, E.; Mordenti, C.; Bagnolo, V.; Cerminara, C.; Chimenti, S.; Bianchi, L.
Journal of Drugs in Dermatology Jdd 12(1): 18-19
2013
ISSN/ISBN: 1545-9616 PMID: 23377323 Document Number: 13126
Document emailed within 1 workday
Related Documents
Köstler, E.; Küster, P. 1981: Inflammatory linear verrucous epidermal nevus (ILVEN) Dermatologische Monatschrift 167(2): 73-79Madnani, N.A.; Misra, B.K. 1999: Inflammatory linear verrucous epidermal nevus and spinal anomaly Indian Journal of Dermatology Venereology and Leprology 65(6): 302
Sayag, J.; Migozzi, M.B.; Adechy, H.; Campana, M.; Weiller, M.M. 1978: Inflammatory linear verrucous epidermal nevus with achromic lesions: ultrastructural study Annales de Dermatologie et de Venereologie 105(10): 871-874
Haustein, U.F. 1984: Xanthomatous cells in inflammatory linear verrucous epidermal nevus or nevoid verruciform xanthoma? Dermatologische Monatschrift 170(7): 475-478
Michel, J.L.; Has, C.; Has, V. 2001: Resurfacing CO2 laser treatment of linear verrucous epidermal nevus European Journal of Dermatology: Ejd 11(5): 436-439
Özdemir, M.; Balevi, A.; Esen, H. 2012: An inflammatory verrucous epidermal nevus concomitant with psoriasis: treatment with adalimumab Dermatology Online Journal 18(10): 11
Toombs, E.L. 2012: Electroplaning of non-inflammatory linear verrucous epidermal nevi (LVEN) Journal of Drugs in Dermatology: Jdd 11(4): 474-477
Borzecki, A.; Strus-Rosińska, B.; Raszewska-Famielec, M.; Sajdak-Wojtaluk, A.; Pilat, P. 2016: Linear verrucous epidermal nevi-effects of carbon dioxide laser therapy Journal of Cosmetic and Laser Therapy 18(6): 348-351
Kim, R.; Marmon, S.; Kaplan, J.; Kamino, H.; Pomeranz, M.Keltz. 2013: Verrucous epidermal nevus Dermatology Online Journal 19(12): 20707
Zgorzalewicz, M. 2000: Bimodal evoked potentials during long-term therapy with conventional or slow release preparations of carbamazepine and valproic acid in children and adolescents with epilepsy Neurologia i Neurochirurgia Polska 34 Suppl. 1: 119-128
Larsen, F.; Menter, A.; Cockerell, C.J.; Wilcox, B.N. 2008: Verrucous linear (segmental) psoriasis of the right leg responding to radiation therapy Journal of Drugs in Dermatology: Jdd 7(10): 969-971
Champel, V.; Radal, M.; Moulin-Vallez, M.; Jonville-Béra, A.P.; Autret-Leca, E. 1999: Should folic acid be given to women treated with valproic acid and/or carbamazepine? Folic acid and pregnancy in epilepsy Revue Neurologique (Paris) 155(3): 220-224
Carmona-Vazquez, C.R.; Ruiz-Garcia, M.; Pena-Landin, D.M.; Diaz-Garcia, L.; Greenawalt, S.R. 2015: The prevalence of obesity and metabolic syndrome in paediatric patients with epilepsy treated in monotherapy with valproic acid Revista de Neurologia 61(5): 193-201
Boldyreva, S.R.; Ermakov, A.I. 2010: Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic occipital lobe epilepsy in children Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(5 Part 1): 39-44
Perrot, H.; Schmitt, D.; Leung, J.; Thivolet, J.; Germain, D. 1971: Hemicorporeal verrucous nevus. Ultrastructural study Annales de Dermatologie et de Syphiligraphie 98(4): 393-400
Garden, A.S.; Benzie, R.J.; Hutton, E.M.; Gare, D.J. 1985: Valproic acid therapy and neural tube defects Canadian Medical Association Journal 132(8): 933; 936
Baskies, A.M. 1984: Case report: pancreatic pseudocyst associated with valproic acid therapy Journal of the Medical Society of New Jersey 81(5): 399-400
Toksoy, H.B.; Tanzer, F.N.; Atalay, A. 1995: Serum carnitine, beta-hydroxybutyrate and ammonia levels during valproic acid therapy Turkish Journal of Pediatrics 37(1): 25-29
Cockerell, O.C.; Sander, J.W.; Shorvon, S.D. 1995: Remission of epilepsy. The NGPS. National General Practice Study of Epilepsy Lancet 346(8984): 1228
Belova, L.V. 1985: Linear pigmented hairy nevus verrucosus Vestnik Dermatologii i Venerologii 5: 49-50